GSK opens new pharma manufacturing facilities with S$130M investment

Pharma |  News | 0 Comment | 08 Jul, 2019

GSK on 5 July 2019, opens new state-of-the-art manufacturing facilities in Singapore following an S$130m investment. The new facilities are located in GSK’s Jurong site and include tw...Read more

21st Interphex Week Japan: Making the event as one of the largest pharma industry events in Asia

Pharma |  Opinion | By Ankit Kankar | 0 Comment | 05 Jul, 2019

5 july 2019 , Tokyo. In Speaking with an official show director of Reed Exhibition , An official summarised an event as below : Close to 45,000 appx  individuals and 1280 Appx Exhibi...Read more

21st Interphex Week Japan concludes in Tokyo

Pharma |  News | By Ankit Kankar | 0 Comment | 05 Jul, 2019

5 July 2019 , Tokyo . Interphex Japan concludes in Tokyo 45,000 appx Visitors from around the world including all concurrent shows . 1280 Appx Exhibitors from 34 countries of world. 300...Read more

Nicox inks €12M worth deal with Ocumension Therapeutics

Pharma |  News | 0 Comment | 05 Jul, 2019

Nicox SA, an international ophthalmology company, and Ocumension Therapeutics have announced they have entered into an exclusive license agreement for the development and com...Read more

GSK gets EU marketing nod for its HIV treatment drug

Pharma |  News | 1 Comment | 04 Jul, 2019

ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, have announced that the European Commission has...Read more

More than 600 Pharma / Cosmetics / Chemical & Biotech executives attended Reed VIP Reception Party

Pharma |  News | By Ankit Kankar | 0 Comment | 04 Jul, 2019

04 July 2019 , Tokyo . The reception was held as a networking event that is greatly appreciated by attendees for gaining  pathways to Japan and the world . VIP Attendes  were ...Read more

LEO Pharma completes the acquisition of Bayer’s dermatology business

Pharma |  News | 0 Comment | 03 Jul, 2019

LEO Pharma and Bayer have announced the achievement of the relevant closing conditions to allow the transfer of Bayer's global prescription dermatology business to LEO Pharma. The companies...Read more

Telix Pharmaceuticals, Grupo RPH sign LATAM manufacturing and distribution agreement

Pharma |  News | 0 Comment | 03 Jul, 2019

Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or &l...Read more

INTERPHEX Japan puts up an impressive show

Pharma |  News | By Ankit Kankar | 0 Comment | 04 Jul, 2019

INTERPHEX JAPAN is Japan's largest and Asia's leading exhibition for pharmaceutical manufacturing and packaging technologies. Including concurrent pharma technology exhibitions, 1,280 exhib...Read more

Alembic Pharma gets USFDA nod for Clonazepam to treat seizures

Pharma |  News | 0 Comment | 02 Jul, 2019

Alembic Pharmaceuticals Limited has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Clonazepam Orally Disintegrating Tab...Read more

Teva announces launch of 1% Sodium Hyaluronate in the US

Pharma |  News | 0 Comment | 02 Jul, 2019

Teva Pharmaceutical Industries Ltd. has announced the launch of 1% Sodium Hyaluronate. The product received approval from the Center for Devices and Radiological Health of the U.S. Food and...Read more

Boehringer Ingelheim inks $870M worth deal with Yuhan Corp

Pharma |  News | 0 Comment | 03 Jul, 2019

Boehringer Ingelheim and Yuhan Corporation have announced a collaboration and license agreement for the development of a first-in-class dual agonist for the treatment of NASH and related li...Read more

Terns appoints Ankang Li as CFO

Pharma |  News | 0 Comment | 02 Jul, 2019

Terns Pharmaceuticals, a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer has announ...Read more

Takeda sells Xiidra to Novartis

Pharma |  News | 0 Comment | 02 Jul, 2019

Takeda has announced the completion of its sale of its Xiidra (lifitegrast ophthalmic solution) 5% product to Novartis for $3.4 billion upfront in cash and up to an additional $1.9 billion ...Read more

CHMP recommends approval of Roche's Tecentriq in combination with Abraxane

Pharma |  News | 0 Comment | 28 Jun, 2019

Roche has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq (atezolizumab)...Read more

J&J’s DARZALEX gets USFDA approval to treat multiple myeloma

Pharma |  News | 0 Comment | 28 Jun, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of DARZALEX® (daratumumab) in combination with lena...Read more

Glenmark receives ANDA approval for Ezetimibe and Simvastatin Tablets

Pharma |  News | 0 Comment | 28 Jun, 2019

Glenmark Pharmaceuticals has been granted final approval by the USFDA for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, a generic version of Vyt...Read more

J&J Innovation opens JLABS @ Shanghai with Shanghai Pharma Engine

Pharma |  News | 0 Comment | 28 Jun, 2019

Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., on 27 June 2019, announced the opening of JLABS @ Shanghai, the world's largest JLABS and t...Read more